3.4300
+0.0600
+(1.78%)
At close: January 30 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-4,782.1230
-5,173.2090
-11,211.2450
-8,710.7240
-8,102.3980
Investing Cash Flow
-3,000.0000
-2,002.7070
-7.4140
-3.1990
-5.4130
Financing Cash Flow
-4,319.6460
-1,641.0660
14,483.1500
37,132.8570
-3,479.1720
End Cash Position
19,625.7800
28,661.4980
37,478.4800
34,213.9890
5,795.0550
Capital Expenditure
--
-2.7070
-7.4140
-3.1990
-5.4130
Issuance of Capital Stock
4,463.0000
--
13,930.0000
23,784.1600
--
Repurchase of Capital Stock
-7,831.6770
-1,000.0000
--
--
--
Free Cash Flow
-4,782.1230
-5,175.9160
-11,218.6590
-8,713.9230
-8,107.8110
12/31/2020 - 12/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
115450.KQ HLB Therapeutics Co.,Ltd.
11,410.00
+0.62%
028300.KQ HLB Co., Ltd.
80,400.00
+1.64%
APVO Aptevo Therapeutics Inc.
4.3800
-1.79%
48Q.F X4 Pharmaceuticals, Inc.
0.6300
-26.91%
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0014
0.00%
AGNPF Algernon Pharmaceuticals Inc.
0.0575
-10.16%
EPRX.TO Eupraxia Pharmaceuticals Inc.
4.4500
+2.06%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.1980
+13.14%
CELUW Celularity Inc.
0.0699
+5.91%
DTIL Precision BioSciences, Inc.
5.01
-3.84%